Amryt Pharma Share Discussion Threads

[papillon] 16/2/2018 18:53

O/T. Bit of a bounce, recently, in cryptocurrency prices, greendragon. Did you profit from the bounce?

[papillon] 16/2/2018 12:32

You're right, greendragon. I should ignore them. They have an agenda. What that agenda is, well people can come to their own conclusions. I wonder if they might have bought at a higher price, pre the September placing and can't get over it. Just sour grapes on their part?

I've always stated that the gap up in November, on the candlestick chart, following the Midas tip in the Mail could be filled. It's often the case that MM's will open up higher than the previous days closing price following a newspaper tip because they anticipate that the tip will mean lots of buyers who will pay the inflated quoted price (the MM's are a crafty lot). However that gap up is often closed as the share price gradually drifts back down again. This invariably happens, though not always. If it does happen I'll have another small top up. That will take me to my £5k maximum bet.

[pottermagic2310] 16/2/2018 12:15

I'm with you re the Golf !!.. and the great outdoors generally... and the 6 Nations

[greendragon777] 16/2/2018 00:02

Haha....I like it Bazworth. With all that in mind, waiting for AMYT's news and results isn't all that bad! 😁

[greendragon777] 15/2/2018 18:41

Well said Speccy1, they have been ramping up the Lojuxta distribution deals and that will translate into revenue and bottom line profits. It would be great if they could find a similar type of licensing deal as it would completely remove the dependency of a positive AP101 result but as Paps said before, these types of deals are probably very difficult to come by in practice but we can only remain hopeful that they might.

I wouldn't bother with those guys Paps, they clearly aren't having a sensible discussion. All the questions will be answered over the next few months and the facts will speak for themselves......whatever they may be! :-)

[papillon] 15/2/2018 18:32

There are many fantasy companies listed on AIM, CTAG & MTV being examples. There are also some downright frauds: MDX comes to mind. I'm confident that AMYT doesn't come into either category. Of course that doesn't mean it will be a success; far from it. It will need to prove itself with results and hence revenue and profits.

Not only is AIM littered with fantasy companies and also some fraudulent ones, the advfn & lse message boards are also populated by fantasists and frauds. radar is obviously a fraudulent poster. A liar with an agenda. Rampers and derampers (like radar) figure an awful lot on theses bb's. They all have an agenda. I wouldn't be surprised to see radar ramping other shares, whilst de-ramping AMYT. Whether he ramps, or deramps, probably depends on whether he holds the shares, or not. I doubt he holds AMYT. Bronxville probably is a reluctant AMYT shareholder who doesn't want to sell at a loss.

[speccy1] 15/2/2018 17:43

Hmm... let me see...

8th Jan - announce Switzerland distribution deal for Lojuxta
10th Jan - announce Central and Eastern Europe distribution deal for Lojuxta
30th Jan - announce Romania and Bulgaria distribution deal for Lojuxta

Three instantly revenue-generating deals in a month and the last one only 2 weeks ago

Yeah - management clearly just twiddling their thumbs...

I'm happy to praise the management from the roof tops - they could have just waited on AP101 and AP102 but they didn't - they went out and found a source of instant revenue and they could easily do it again.

The comments on lse strike me as a deliberate attempt to spook PIs out of their shares so the posters can top up cheaper, or maybe they're being paid by someone who wants in.

[papillon] 15/2/2018 13:17

Meanwhile radar & Bronxville continue to post UTTER BOLLACKS on the lse bb. It's just a question of waiting for news. It may be good, or bad, but one needs patience. Take N4P as an example. Speculative AIM shares only move on news, otherwise the sp's just drift on low volume. Both radar & Bronxville are as thick as two short planks. If they haven't got any patience and are not prepared to take the risk why don't the pair just sell and p*ss off?

radar
Posts: 2,698
Off Topic
Opinion: No Opinion
Price: 18.875
RE: AP102- dead in the water? Today 12:42 Agreed and its now slipping for a reason.

Bronxville
Posts: 94
Off Topic
Opinion: No Opinion
Price: 18.875
AP102- dead in the water? Today 12:21 Nothing for over a year..

Bronxville
Posts: 94
Off Topic
Opinion: No Opinion
Price: 18.95
RE: Gone to sleep Today 10:21 I can understand no news but the lack of volume is a indictment of management.

radar
Posts: 2,698
Off Topic
Opinion: No Opinion
Price: 18.95
Gone to sleep Today 09:03 Are the management gone asleep or on their holidays all the time, it looks like it.

[papillon] 15/2/2018 13:07

In the meantime one can sell at 18.50p and buy at 18.70p. The mid price of 18.875p quoted on the financial web sites is a complete nonsense. In the continuing absence of news the gap up in November following the Midas tip in the Mail is looking ever more likely to be "closed" by the AMYT share price gradually drifting lower on low volume.

PS. N4P was drifting sideways at under 6p in the summer, greendragon, but subsequent good news propelled the share price to over 30p, a 5 fold rise in just a few months. We can only hope that AMYT issue a stream of perceived good news, like N4P. Fingers crossed!

[greendragon777] 14/2/2018 23:42

Off course it'll be good news Paps.....bad news is simply not an option! 😃😃😃

Year end accounts, interim EASE trial results, possible new Lojuxta distribution agreements and possible new licensing deals are all events that could be announced any day which could affect the share price significantly.

Lots to look forward to! 👍

[papillon] 14/2/2018 12:06

The volume so far today is even lower than what it was at this time yesterday. Just over £1k in total. LOL. Are you refilling your water bottle with tap water, instead of buying a fresh one, greendragon? Please get back on the coffee pronto! LOL.

I'd have expected some speculative buying interest in AMYT when the AP101 interim results are. apparently, so near, but it appears to be not the case.

[greendragon777] 13/2/2018 16:00

This time it was for a bottle of water Paps, I'm off the coffee! 😂😂😂

[papillon] 13/2/2018 14:39

Come on chaps! Own up! Who bought 7 shares @ 19.25p (cost £1.35 + commission) and sold 25 @ 18.80p (cost £4.70 + commission)??

No doubt about it AMYT certainly attracts the high rollers. Could they be II trades, or just wealthy individuals trading? LOL.

Watching the AMYT share price is like watching paint dry, or grass growing. If only I had more than one share to take an interest in. N4P for example! LOL.

I think Jacksonpollack was wrong to think the AMYT share price will drop back to the low teens again, however he was completely right to sell @ 27p back in the summer and look to buy back in cheaper before the AP101 results are released. Really good news drives sp's upwards (or downwards if the news is really bad) and the AP101 news was always going to be the major driver of the share price

Still it's too late to sell now. I'm here for the AP101 news, whether it be really good, or bad. I don't expect that news until April onwards, but I would like it asap as I'm getting rather bored with watching paint dry! LOL

[greendragon777] 12/2/2018 15:14

Full year accounts were out 30th March last year so maybe some forecasts on Lojuxta sales around then.

[papillon] 12/2/2018 14:08

AMYT hasn't bounced back in line with the general market recovery today, unlike N4P, greendragon, because N4P have had their good news issued recently whereas we are still awaiting AMYT's. With N4P there were a lot of shareholders with big paper profits who panicked last week as the markets crashed and converted their paper profits into cash. However there are still N4P bulls around following on from the recent good news who have returned to buy N4P as the market recovers.

There is no such speculative interest in AMYT (be it bullish, or bearish) at the moment, hence the continuing apparent drift sideways. Hence last weeks gradual drift downwards in AMYT in line with the plunging market last week hasn't been reversed as the general market recovers. At best we go sideways. You never know we might get another update on Lojuxta which can cause a small increase in the share price as we have already seen a few times this year.

I'm not expecting AP101 news until April onwards. It would be nice in March, but I'm not banking on it.

[greendragon777] 12/2/2018 13:26

Totally agree Paps, it'll either be a really really good day or a really really bad day when the interims are announced....there will be no in between. 18p or 22p will be insignificant. I think my aggregate is circa 23p at this stage and whilst I would obviously preferred to be set at 18p (or 14p from it's lows) it doesn't bother me at all, it's virtually impossible to get the time right with these things in the short term.

At least the markets have bounced back have bounced back for now so hopefully that'll stop the slide in AMYT. Funny the way AMYT doesn't come back with the general market recovery but I guess it's been sliding for a good while now. As you say, we need some good news at this point and what better good news could we ask for than a positive interim EASE Phase III trial result! :-)

[papillon] 12/2/2018 12:49

We must accept that anyone buying AMYT shares now is taking a punt on AP101 being deemed a success. I've had a £4.5k punt on AMYT (£5k is my limit on a share). I'm not an insider, nor have I any medical background so I can't put any accurate figure on the Chance of Success (CoS) for AP101, but am hopeful it is greater than 50%. Fingers crossed.

PS. Whether you paid 22p, or 18p, for your shares will be immaterial when the AP101 interim trial results are issued. You'll make a big gain, or a big loss, whether you paid 22p, or 18p.

PS. I see that N4P has risen by circa 20% today as confidence has returned to the Market today (FTSE strong). However I think it has peaked (unless further good news is released).

Whereas the AMYT share price has not recovered today in line with the Market. Why? Because we are awaiting news whereas N4P have recently issued good news. There is still bullish interest in N4P following that recent good news, but that bullish interest will gradually evaporate IMO.

[papillon] 12/2/2018 11:55

Tiny volume so far today. Buys going through at below mid price @ 18.95p so being marked down as sells. You can sell @ 18.80p. Though these figures are for small trades only. I reckon the share price could drift marginally lower in the days ahead in the absence of good news.

Current AMYT Mkt Cap is £52.28m. There is a loan of 10m Euro's from the EIB (the other 10m has yet to be drawn down). So AMYT is currently really being valued at circa £60m.

I reckon a failure of AP101 could cause the AMYT Mkt Cap to plunge by between 50-70% whereas success could cause a similar rise, perhaps even higher.

[greendragon777] 11/2/2018 23:27

I had a quick look over the analyst report from Beaufort they put out in May of last year. They stated Q1 for the interims but AMYT's management seem to use H1 in any reference to the interims so take from that what you will.

I'm now thinking late March early April but it could obviously come a lot sooner than that. One way or the other we're in the twilight zone with not long to go! 😁

[papillon] 11/2/2018 21:51

Why 4-5 weeks?